![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 15321 |
FusionGeneSummary for GPX3_NSMCE1 |
![]() |
Fusion gene information | Fusion gene name: GPX3_NSMCE1 | Fusion gene ID: 15321 | Hgene | Tgene | Gene symbol | GPX3 | NSMCE1 | Gene ID | 2878 | 197370 |
Gene name | glutathione peroxidase 3 | NSE1 homolog, SMC5-SMC6 complex component | |
Synonyms | GPx-P|GSHPx-3|GSHPx-P | NSE1 | |
Cytomap | 5q33.1 | 16p12.1 | |
Type of gene | protein-coding | protein-coding | |
Description | glutathione peroxidase 3GPx-3extracellular glutathione peroxidaseglutathione peroxidase 3 (plasma)plasma glutathione peroxidase | non-structural maintenance of chromosomes element 1 homolognon-SMC element 1 homolog | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | P22352 | Q8WV22 | |
Ensembl transtripts involved in fusion gene | ENST00000388825, ENST00000521722, ENST00000517973, | ENST00000361439, ENST00000565384, | |
Fusion gene scores | * DoF score | 8 X 11 X 3=264 | 2 X 3 X 3=18 |
# samples | 14 | 3 | |
** MAII score | log2(14/264*10)=-0.915111102413487 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: GPX3 [Title/Abstract] AND NSMCE1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GPX3 | GO:0051289 | protein homotetramerization | 3693360 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | CV421185 | GPX3 | chr5 | 150408223 | - | NSMCE1 | chr16 | 27238540 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-intron | ENST00000388825 | ENST00000361439 | GPX3 | chr5 | 150408223 | - | NSMCE1 | chr16 | 27238540 | - |
3UTR-intron | ENST00000388825 | ENST00000565384 | GPX3 | chr5 | 150408223 | - | NSMCE1 | chr16 | 27238540 | - |
intron-intron | ENST00000521722 | ENST00000361439 | GPX3 | chr5 | 150408223 | - | NSMCE1 | chr16 | 27238540 | - |
intron-intron | ENST00000521722 | ENST00000565384 | GPX3 | chr5 | 150408223 | - | NSMCE1 | chr16 | 27238540 | - |
intron-intron | ENST00000517973 | ENST00000361439 | GPX3 | chr5 | 150408223 | - | NSMCE1 | chr16 | 27238540 | - |
intron-intron | ENST00000517973 | ENST00000565384 | GPX3 | chr5 | 150408223 | - | NSMCE1 | chr16 | 27238540 | - |
Top |
FusionProtFeatures for GPX3_NSMCE1 |
![]() |
Hgene | Tgene |
GPX3 | NSMCE1 |
Protects cells and enzymes from oxidative damage, bycatalyzing the reduction of hydrogen peroxide, lipid peroxides andorganic hydroperoxide, by glutathione. | RING-type zinc finger-containing E3 ubiquitin ligasethat assembles with melanoma antigen protein (MAGE) to catalyzethe direct transfer of ubiquitin from E2 ubiquitin-conjugatingenzyme to a specific substrate. Within MAGE-RING ubiquitin ligasecomplex, MAGE stimulates and specifies ubiquitin ligase activitylikely through recruitment and/or stabilization of the E2ubiquitin-conjugating enzyme at the E3:substrate complex. Involvedin maintenance of genome integrity, DNA damage response and DNArepair (PubMed:29225034, PubMed:20864041). NSMCE3/MAGEG1 andNSMCE1 ubiquitin ligase are components of SMC5-SMC6 complex andmay positively regulate homologous recombination-mediated DNArepair (PubMed:18086888). MAGEF1-NSMCE1 ubiquitin ligase promotesproteasomal degradation of MMS19, a key component of the cytosoliciron-sulfur protein assembly (CIA) machinery. Down-regulation ofMMS19 impairs the activity of several DNA repair and metabolismenzymes such as ERCC2/XPD, FANCJ, RTEL1 and POLD1 that requireiron-sulfur clusters as cofactors (PubMed:29225034).{ECO:0000269|PubMed:18086888, ECO:0000269|PubMed:20864041,ECO:0000269|PubMed:29225034}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GPX3_NSMCE1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GPX3_NSMCE1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GPX3_NSMCE1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | GPX3 | P22352 | DB00143 | Glutathione | Glutathione peroxidase 3 | small molecule | approved|investigational|nutraceutical |
Top |
RelatedDiseases for GPX3_NSMCE1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GPX3 | C0014175 | Endometriosis | 2 | CTD_human |
Hgene | GPX3 | C0024121 | Lung Neoplasms | 2 | CTD_human |
Hgene | GPX3 | C0028754 | Obesity | 2 | CTD_human |
Hgene | GPX3 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | GPX3 | C0015624 | Fanconi Syndrome | 1 | CTD_human |
Hgene | GPX3 | C0021655 | Insulin Resistance | 1 | CTD_human |
Hgene | GPX3 | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | GPX3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | GPX3 | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |